Maik Jornitz (G-CON Manufacturing Inc.): I am known as
Jornitz: The conservatism of change. Our industry unfortunately is bound to be
a subject matter expert for filtration and single-use technology in the pharma-
ceutical and biopharmaceutical industry, and I train industry and regulators on
a frequent basis. I edited and authored 10 books, 15 book chapters, and over
100 scientific papers.
conservative due to regulatory restrictions that hinder rapid progress in pro-
cessing and facility designs.
INTERPHEX: What are you most passionate about professionally? What most
excites you about your work and the contribution(s) you make?
Jornitz: I am passionate about filtration and aseptic processing. I think there is
a lot we can optimize and a lot we can learn. We all have to work together to
accumulate specific knowledge and experience and then convey this to benefits
for the clients we serve and the ultimate client: the patient.
INTERPHEX: Professional and/or recognition(s)?
Jornitz: Multiple awards, including the Martin Van Trieste Pharmaceutical
Science Award presented to me by PDA and book awards. I have also been the
Chairman of the PDA Board of Directors.
INTERPHEX: What is your biggest success thus far in your career? What has
contributed to this success?
Jornitz: I consider my biggest success to be building highly-effective and mo-
tivated teams. I thoroughly enjoy when teams work together to accomplish the
tasks at hand. The highest fulfillment and satisfaction is to see teams and indi-
viduals becoming successful within their role in an organization or industry.
INTERPHEX: Where do you see the industry going in the next 10 years?
Your area of expertise?
Jornitz: We will see more flexible manufacturing processes and facilities, smaller
INTERPHEX: What would you consider to be a major achievement for the
volumes, and smaller footprints, but way more agile. In addition, we will see
more personalized therapies, which demand by far different processing systems
than we have nowadays. I also hope that we see the detection of specific cancer
markers and may be able to treat those with cancer vaccines.
industry in the near future?
Jornitz: I believe we will see more break-through cancer treatments, which are
more targeted to specific cancers and personalized to specific patients. n
tell us how your
are you known for
professionally? What is your area of
Cetinkaya: Pharmaceutical process
monitoring with ultrasound.
INTERPHEX: What path brought you
to your area of expertise?
Cetinkaya: My interactions with
INTERPHEX: What is the biggest chal-
lenge you have faced in the industry?
Cetinkaya: Finding practical applica-
tions to my research ideas.
INTERPHEX: What advice would you
give to a professional starting out in
Cetinkaya: Have an open mind and
always remember that it is your re-
sponsibility to explain your ideas.
INTERPHEX: What are you most pas-
sionate about professionally? What
most excites you about your work
and the contribution(s) you make?
Cetinkaya: Seeing my ideas imple-
mented in a practical system.
INTERPHEX: What are you looking
forward to at INTERPHEX this year?
Cetinkaya: Learning more about new
WEDNESDAY n APRIL 27 n 2016